This week, I welcome Dr. Jeff Stanley of Virta Health back to the podcast to discuss the results from their one-year Cardiovascular Risk Factor Assessment clinical trial. The results, which are published in the peer-reviewed publication Cardiovascular Diabetology, include some very impressive findings. Findings that may just shake up conventional wisdom about a high fat diet. During our conversation, we discuss the details of the trial, and also explore practical implications of a ketogenic diet, intermittent fasting, macro calculations, and beta-hydroxybutyrate measurements. Dr Stanley and Virta health have already revolutionized the way we treat diabetes, and this latest trial only furthers that mission.
[4:31] Virta Health's method is to safely and sustainably reverse type 2 diabetes.
[9:08] New data will soon be published by Virta.
[13:42] The guidelines and macro data Virta uses with patients.
[19:25] Advice for people seeking information on a ketogenic diet from their doctor.
[22:15] Obstacles patients face with staying compliant to treatment and lifestyle changes.
[26:12] Virta's priority when discussing intermittent fasting is safety, safety, safety.
[30:26] What does the cardiovascular intervention trial data show after one year?
[51:55] What pushback is Virta experiencing after publishing their results?
Mentioned in This Episode:
This Episode is Sponsored by:
Oura Ring Sleep Tracking Technology helps improve your understanding of the depth, quality, and length of your sleep. Visit OuraRing.com and at checkout use the code 'LOWCARBCARDIOLOGIST' to get $50 off your order.